+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Brachytherapy Market by Dose Rate, End User, Product, Treatment Type, Application - Global Forecast to 2030- Product Image
Brachytherapy Market by Dose Rate, End User, Product, Treatment Type, Application - Global Forecast to 2030- Product Image
Sale

Brachytherapy Market by Dose Rate, End User, Product, Treatment Type, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083897
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Brachytherapy Market grew from USD 1.01 billion in 2024 to USD 1.07 billion in 2025. It is expected to continue growing at a CAGR of 5.84%, reaching USD 1.42 billion by 2030.

Setting the Stage for Brachytherapy’s Next Era

Brachytherapy stands at a pivotal juncture, offering a targeted approach to cancer treatment that delivers radiation directly to malignant tissues while sparing surrounding healthy structures. As treatment protocols evolve and technology advances, stakeholders across healthcare delivery, medical device manufacturing, and regulatory bodies are seeking clarity on the forces shaping this dynamic market. This executive summary distills critical findings and insights designed to equip decision-makers with an in-depth understanding of prevailing and emerging trends, from technological breakthroughs to policy shifts.

The ensuing analysis navigates complex factors driving demand, including patient demographics, clinical adoption rates, and reimbursement landscapes. It highlights how precision medicine and personalized oncology are catalyzing new applications for brachytherapy, while also examining the interplay between established techniques and next-generation devices. By framing these developments within the broader context of healthcare economics and global regulatory considerations, this report provides a holistic view of market trajectories and investment opportunities.

Transformative Trends Redefining the Brachytherapy Landscape

The brachytherapy ecosystem is undergoing transformative shifts fueled by convergence of technological innovation, clinical evidence, and market consolidation. Novel high dose rate platforms are redefining treatment times and patient throughput, while remote afterloader systems are enhancing operational safety through automated delivery. Concurrently, the integration of advanced imaging modalities has elevated the precision of applicator placement, fostering improved local control and reduced side-effect profiles.

On the acquisition front, strategic alliances and mergers have intensified, as leading device manufacturers seek to broaden their product portfolios and geographic reach. Meanwhile, emerging players are differentiating through single-use applicator accessories and hybrid treatment solutions that blend brachytherapy with external beam radiation. These competitive moves underscore a broader industry pivot toward value-based care models, where clinical efficacy, cost containment, and patient experience converge to redefine success metrics.

Examining the Cumulative Impact of United States Tariffs in 2025

In 2025, newly implemented cumulative U.S. tariffs on imported medical isotopes and specialized radiation delivery components have introduced fresh layers of complexity for device producers and clinical end users alike. The incremental cost burden associated with tariff duties on raw materials such as cesium-137 sources and precision-engineered transfer devices has exerted upward pressure on equipment pricing and consumable cartridges. This, in turn, has compelled healthcare institutions to reassess procurement strategies and inventory management practices to mitigate budgetary constraints.

Moreover, the cascading effects of these duties have prompted several manufacturers to explore onshore assembly and source encapsulation partnerships, seeking to localize production and insulate supply chains from geopolitical volatility. While these initiatives promise long-term resilience, they also require upfront capital investments and regulatory recalibrations. For radiation oncology departments, navigating the tariff-induced cost paradigm will hinge on forging closer collaborations with vendors to secure volume discounts and service level agreements that balance affordability with uninterrupted clinical operations.

Unlocking Market Potential through Strategic Segmentation Insights

A nuanced comprehension of market segments reveals where targeted growth and competitive pressure converge. When examining delivery rates, high dose rate systems dominate capital investment cycles owing to their operational efficiency, while low dose rate offerings maintain a stable foothold in resource-constrained settings. Pulse dose rate solutions are carving a niche among centers prioritizing fractionation flexibility and outpatient workflows. Regarding care settings, ambulatory surgical centers have emerged as agile adopters of compact afterloader units, cancer institutes leverage comprehensive applicator portfolios for complex case mixes, and hospitals continue to underpin volume-driven utilization across diverse treatment types.

Dissecting the device landscape further, afterloaders split into manual and remote-controlled configurations, each fulfilling distinct clinical protocols. Applicators and accessories range from intracavitary frameworks to precision-engineered needles and transfer tools. Radioactive sources encompass a spectrum from long-lived cesium isotopes to iodine, iridium, palladium, and yttrium variants tailored to specific tissue kinetics. Treatment types span interstitial placements deeply embedded within tissue matrices, intracavitary cavities following anatomical contours, and surface modalities targeting superficial malignancies. Applications extend across breast interventions using hybrid, MammoSite, and SAVIScout platforms; gynecological therapies employing both interstitial and intracavitary approaches; head and neck treatments for laryngeal, oral, and oropharyngeal sites; and prostate protocols offering permanent seed implants alongside temporary high dose rate insertions. This segmentation framework illuminates both saturated pockets and untapped corridors for innovation and market penetration.

Regional Dynamics Shaping Brachytherapy Adoption

Geographic dynamics are instrumental in shaping adoption curves and investment priorities. In the Americas, robust reimbursement frameworks and an expanding network of specialized radiation oncology centers drive demand for cutting-edge brachytherapy solutions. North American institutions, in particular, emphasize high throughput platforms integrated with image-guided workflows, while Latin American markets are witnessing gradual transitions from low dose rate models toward high dose rate offerings as infrastructure and training programs mature.

Across Europe, Middle East and Africa, diverse regulatory environments and healthcare funding mechanisms create a mosaic of opportunity. Western European nations prioritize interoperability standards and value-based procurement, whereas emerging markets in the Middle East are channeling capital into state-of-the-art cancer institutes. In Africa, public-private partnerships play a critical role in bolstering access to isotopes and applicator technologies. The Asia-Pacific region displays a dichotomy between advanced markets with established brachytherapy programs and high-growth economies where government initiatives are rapidly scaling multisite treatment centers. These regional patterns underscore the importance of adaptive market entry strategies calibrated to local clinical practices and reimbursement landscapes.

Evaluating Competitive Strategies among Leading Players

Key industry players are deploying diverse tactics to secure leadership positions in brachytherapy. Major medical technology conglomerates are investing heavily in next-generation afterloader platforms, integrating real-time dosimetry and workflow automation to enhance safety and throughput. At the same time, specialized isotopes providers are forging strategic alliances with research hospitals to accelerate clinical validation of novel source chemistries. Mid-market innovators are capitalizing on modular accessory designs, allowing practitioners to tailor applicator configurations for niche indications while streamlining sterilization and inventory control.

Competitive differentiation also hinges on service ecosystems. Leading suppliers are expanding technical training programs and remote support networks, enabling smaller clinics to adopt advanced protocols with confidence. Simultaneously, several companies have introduced bundled service models that encompass preventive maintenance, source replacement, and software upgrades under unified contracts. This shift toward integrated solutions reflects a broader industry move away from transactional sales toward outcome-oriented partnerships that align vendor incentives with clinical performance metrics.

Strategic Recommendations for Industry Leadership

Industry leaders should prioritize innovation in high dose rate systems, focusing on enhancements in automation, user interface simplicity and real-time imaging integration to meet rising clinical demand for precision workflows. Developing localized assembly capabilities and regional service hubs can attenuate the impact of external tariffs and streamline supply chain resilience. Furthermore, aligning product roadmaps with reimbursement reform initiatives will facilitate market access by demonstrating economic value alongside clinical efficacy.

Building deeper collaborations with oncology centers through co-development agreements and knowledge exchange programs can accelerate adoption of novel applicator and source combinations. Emphasizing outcome data in real-world settings will strengthen payer and provider confidence in emerging therapies. Finally, tailoring market entry strategies to regional reimbursement paradigms and infrastructure maturity-whether in advanced economies or high-growth Asia-Pacific and Latin American markets-will enable more precise allocation of commercial resources and amplify return on investment.

Underpinning Insights with Rigorous Research Methodology

This research synthesizes insights from a comprehensive methodology combining primary interviews with leading oncologists, medical physicists and procurement directors alongside rigorous secondary research encompassing peer-reviewed publications, regulatory filings, and company disclosures. Data triangulation between clinical trial registries and real-world evidence databases ensures both statistical validity and practical relevance. The segmentation framework was refined through iterative validation workshops with subject-matter experts to reflect nuanced distinctions in dose rates, end-user profiles, product typologies, treatment modalities and anatomical applications.

Regional analyses draw upon policy reviews and reimbursement schedules, supplemented by in-country market intelligence gathered from local distributors and healthcare associations. Competitive landscape assessments leverage patent analytics and financial performance metrics, while tariff impact modeling integrates customs data with component cost breakdowns. Quality controls were enforced through multiple peer reviews and consistency checks, yielding findings that withstand rigorous scrutiny and provide a reliable foundation for strategic decision-making.

Concluding Perspectives on Brachytherapy’s Evolution

Brachytherapy is poised to enter a new chapter defined by technological sophistication, strategic realignments, and evolving policy environments. As high dose rate platforms and remote afterloader systems become increasingly ubiquitous, the competitive stakes will shift toward service excellence, cost containment and regulatory agility. Regional disparities in reimbursement and infrastructure will continue to present both challenges and opportunities, demanding localized approaches informed by granular market intelligence.

By leveraging a robust segmentation paradigm and understanding the ramifications of tariff policies, industry stakeholders can anticipate market shifts, optimize resource allocation and foster collaborative partnerships that drive clinical adoption. This comprehensive analysis underscores the critical interplay between innovation, regulatory frameworks and competitive dynamics, paving the way for informed strategies that harness the full potential of brachytherapy’s precision oncology promise.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Dose Rate
    • High Dose Rate
    • Low Dose Rate
    • Pulse Dose Rate
  • End User
    • Ambulatory Surgical Centers
    • Cancer Institutes
    • Hospitals
  • Product
    • Afterloaders
      • Manual
      • Remote
    • Applicator And Accessory
      • Applicators
      • Needles
      • Transfer Devices
    • Sources
      • Cs-137
      • I-125
      • Ir-192
      • Pd-103
      • Y-90
  • Treatment Type
    • Interstitial
    • Intracavitary
    • Surface
  • Application
    • Breast
      • Hybrid
      • MammoSite
      • SAVIScout
    • Gynecological
      • Interstitial
      • Intracavitary
      • Surface
    • Head And Neck
      • Laryngeal
      • Oral
      • Oropharyngeal
    • Prostate
      • Permanent Implant
      • Temporary Implant
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Varian Medical Systems, Inc.
  • Elekta AB (publ)
  • C.R. Bard, Inc.
  • Eckert & Ziegler AG
  • Ion Beam Applications S.A.
  • Best Medical International, Inc.
  • IsoRay, Inc.
  • Theragenics Corporation
  • Beijing Atom High Tech Co., Ltd.
  • NTP Radioisotopes SOC Limited

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Brachytherapy Market, by Dose Rate
8.1. Introduction
8.2. High Dose Rate
8.3. Low Dose Rate
8.4. Pulse Dose Rate
9. Brachytherapy Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Cancer Institutes
9.4. Hospitals
10. Brachytherapy Market, by Product
10.1. Introduction
10.2. Afterloaders
10.2.1. Manual
10.2.2. Remote
10.3. Applicator And Accessory
10.3.1. Applicators
10.3.2. Needles
10.3.3. Transfer Devices
10.4. Sources
10.4.1. Cs-137
10.4.2. I-125
10.4.3. Ir-192
10.4.4. Pd-103
10.4.5. Y-90
11. Brachytherapy Market, by Treatment Type
11.1. Introduction
11.2. Interstitial
11.3. Intracavitary
11.4. Surface
12. Brachytherapy Market, by Application
12.1. Introduction
12.2. Breast
12.2.1. Hybrid
12.2.2. MammoSite
12.2.3. SAVIScout
12.3. Gynecological
12.3.1. Interstitial
12.3.2. Intracavitary
12.3.3. Surface
12.4. Head And Neck
12.4.1. Laryngeal
12.4.2. Oral
12.4.3. Oropharyngeal
12.5. Prostate
12.5.1. Permanent Implant
12.5.2. Temporary Implant
13. Americas Brachytherapy Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Brachytherapy Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Brachytherapy Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Varian Medical Systems, Inc.
16.3.2. Elekta AB (publ)
16.3.3. C.R. Bard, Inc.
16.3.4. Eckert & Ziegler AG
16.3.5. Ion Beam Applications S.A.
16.3.6. Best Medical International, Inc.
16.3.7. IsoRay, Inc.
16.3.8. Theragenics Corporation
16.3.9. Beijing Atom High Tech Co., Ltd.
16.3.10. NTP Radioisotopes SOC Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BRACHYTHERAPY MARKET MULTI-CURRENCY
FIGURE 2. BRACHYTHERAPY MARKET MULTI-LANGUAGE
FIGURE 3. BRACHYTHERAPY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BRACHYTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BRACHYTHERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BRACHYTHERAPY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BRACHYTHERAPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BRACHYTHERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BRACHYTHERAPY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BRACHYTHERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BRACHYTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BRACHYTHERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BRACHYTHERAPY MARKET SIZE, BY HIGH DOSE RATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BRACHYTHERAPY MARKET SIZE, BY LOW DOSE RATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BRACHYTHERAPY MARKET SIZE, BY PULSE DOSE RATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BRACHYTHERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BRACHYTHERAPY MARKET SIZE, BY CANCER INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BRACHYTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BRACHYTHERAPY MARKET SIZE, BY MANUAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BRACHYTHERAPY MARKET SIZE, BY REMOTE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BRACHYTHERAPY MARKET SIZE, BY APPLICATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BRACHYTHERAPY MARKET SIZE, BY NEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BRACHYTHERAPY MARKET SIZE, BY TRANSFER DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BRACHYTHERAPY MARKET SIZE, BY SOURCES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BRACHYTHERAPY MARKET SIZE, BY CS-137, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BRACHYTHERAPY MARKET SIZE, BY I-125, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BRACHYTHERAPY MARKET SIZE, BY IR-192, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BRACHYTHERAPY MARKET SIZE, BY PD-103, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BRACHYTHERAPY MARKET SIZE, BY Y-90, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BRACHYTHERAPY MARKET SIZE, BY INTERSTITIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BRACHYTHERAPY MARKET SIZE, BY INTRACAVITARY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BRACHYTHERAPY MARKET SIZE, BY SURFACE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BRACHYTHERAPY MARKET SIZE, BY BREAST, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BRACHYTHERAPY MARKET SIZE, BY HYBRID, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BRACHYTHERAPY MARKET SIZE, BY MAMMOSITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BRACHYTHERAPY MARKET SIZE, BY SAVISCOUT, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BRACHYTHERAPY MARKET SIZE, BY INTERSTITIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BRACHYTHERAPY MARKET SIZE, BY INTRACAVITARY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BRACHYTHERAPY MARKET SIZE, BY SURFACE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BRACHYTHERAPY MARKET SIZE, BY LARYNGEAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BRACHYTHERAPY MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BRACHYTHERAPY MARKET SIZE, BY OROPHARYNGEAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BRACHYTHERAPY MARKET SIZE, BY PROSTATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BRACHYTHERAPY MARKET SIZE, BY PERMANENT IMPLANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BRACHYTHERAPY MARKET SIZE, BY TEMPORARY IMPLANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 81. CANADA BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 82. CANADA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. CANADA BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. CANADA BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 85. CANADA BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 86. CANADA BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 87. CANADA BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 88. CANADA BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. CANADA BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 90. CANADA BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 91. CANADA BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 92. CANADA BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 93. MEXICO BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 94. MEXICO BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. MEXICO BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. MEXICO BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 97. MEXICO BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 98. MEXICO BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 99. MEXICO BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 100. MEXICO BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. MEXICO BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 102. MEXICO BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 103. MEXICO BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 104. MEXICO BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 154. GERMANY BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 155. GERMANY BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. GERMANY BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. GERMANY BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 158. GERMANY BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 159. GERMANY BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 160. GERMANY BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 161. GERMANY BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. GERMANY BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 163. GERMANY BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 164. GERMANY BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 165. GERMANY BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 166. FRANCE BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 167. FRANCE BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. FRANCE BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. FRANCE BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 170. FRANCE BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 171. FRANCE BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 172. FRANCE BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 173. FRANCE BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. FRANCE BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 175. FRANCE BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 176. FRANCE BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 177. FRANCE BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 183. RUSSIA BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 184. RUSSIA BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 185. RUSSIA BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 190. ITALY BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 191. ITALY BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. ITALY BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. ITALY BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 194. ITALY BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 195. ITALY BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 196. ITALY BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 197. ITALY BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. ITALY BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 199. ITALY BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 200. ITALY BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 201. ITALY BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 202. SPAIN BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 203. SPAIN BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. SPAIN BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. SPAIN BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 206. SPAIN BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 207. SPAIN BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 208. SPAIN BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 209. SPAIN BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. SPAIN BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 211. SPAIN BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 212. SPAIN BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 213. SPAIN BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 226. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 248. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 250. DENMARK BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 251. DENMARK BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. DENMARK BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 253. DENMARK BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 254. DENMARK BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 255. DENMARK BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 256. DENMARK BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 257. DENMARK BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. DENMARK BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 259. DENMARK BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 260. DENMARK BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 261. DENMARK BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 271. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 272. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 273. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 274. QATAR BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 275. QATAR BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. QATAR BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 277. QATAR BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 278. QATAR BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 279. QATAR BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 280. QATAR BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 281. QATAR BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. QATAR BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 283. QATAR BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 284. QATAR BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 285. QATAR BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 286. FINLAND BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 287. FINLAND BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. FINLAND BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 289. FINLAND BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 290. FINLAND BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 291. FINLAND BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 292. FINLAND BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 293. FINLAND BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. FINLAND BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 295. FINLAND BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 296. FINLAND BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 297. FINLAND BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 303. SWEDEN BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 304. SWEDEN BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 305. SWEDEN BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. SWEDEN BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 307. SWEDEN BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 308. SWEDEN BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 309. SWEDEN BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 310. NIGERIA BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 311. NIGERIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. NIGERIA BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 313. NIGERIA BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 314. NIGERIA BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 315. NIGERIA BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 316. NIGERIA BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 317. NIGERIA BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 318. NIGERIA BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 319. NIGERIA BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 320. NIGERIA BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 321. NIGERIA BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 322. EGYPT BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 323. EGYPT BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 324. EGYPT BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 325. EGYPT BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 326. EGYPT BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 327. EGYPT BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 328. EGYPT BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 329. EGYPT BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 330. EGYPT BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 331. EGYPT BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 332. EGYPT BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 333. EGYPT BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 334. TURKEY BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 335. TURKEY BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 336. TURKEY BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 337. TURKEY BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 338. TURKEY BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 339. TURKEY BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 340. TURKEY BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 341. TURKEY BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 342. TURKEY BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 343. TURKEY BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 344. TURKEY BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 345. TURKEY BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 346. ISRAEL BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 347. ISRAEL BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 348. ISRAEL BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 349. ISRAEL BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 350. ISRAEL BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 351. ISRAEL BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 352. ISRAEL BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 353. ISRAEL BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 354. ISRAEL BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 355. ISRAEL BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 356. ISRAEL BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 357. ISRAEL BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 358. NORWAY BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 359. NORWAY BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 360. NORWAY BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 361. NORWAY BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 362. NORWAY BRACHYTHERAPY MARKET SIZE, BY APPLICATOR AND ACCESSORY, 2018-2030 (USD MILLION)
TABLE 363. NORWAY BRACHYTHERAPY MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 364. NORWAY BRACHYTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 365. NORWAY BRACHYTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 366. NORWAY BRACHYTHERAPY MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 367. NORWAY BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL, 2018-2030 (USD MILLION)
TABLE 368. NORWAY BRACHYTHERAPY MARKET SIZE, BY HEAD AND NECK, 2018-2030 (USD MILLION)
TABLE 369. NORWAY BRACHYTHERAPY MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 370. POLAND BRACHYTHERAPY MARKET SIZE, BY DOSE RATE, 2018-2030 (USD MILLION)
TABLE 371. POLAND BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 372. POLAND BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 373. POLAND BRACHYTHERAPY MARKET SIZE, BY AFTE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Brachytherapy market report include:
  • Varian Medical Systems, Inc.
  • Elekta AB (publ)
  • C.R. Bard, Inc.
  • Eckert & Ziegler AG
  • Ion Beam Applications S.A.
  • Best Medical International, Inc.
  • IsoRay, Inc.
  • Theragenics Corporation
  • Beijing Atom High Tech Co., Ltd.
  • NTP Radioisotopes SOC Limited

Table Information

Report AttributeDetails
No. of Pages190
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.07 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.42 Billion
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Breast Cancer Brachytherapy Market Size, Share & Trends Analysis Report By Technology (HDR, LDR), By Product (Applicators And Afterloaders, Electronic Brachytherapy), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Breast Cancer Brachytherapy Market Size, Share & Trends Analysis Report By Technology (HDR, LDR), By Product (Applicators And Afterloaders, Electronic Brachytherapy), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Brachytherapy Market Report 2025 - Product Image

Brachytherapy Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Brachytherapy Devices Market Report 2025 - Product Image

Brachytherapy Devices Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Brachytherapy Treatment Planning System Market by Application, Treatment Type, End User, Component - Global Forecast to 2030 - Product Image

Brachytherapy Treatment Planning System Market by Application, Treatment Type, End User, Component - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Radiotherapy Market by Technology (EBRT:MR LINAC, Stereotactic, Particle; IBRT/Brachytherapy, Cobalt-60 Teletherapy), Procedure (IGRT, IMRT, 3D-CRT, HDR, LDR, PDR), Cancer (Prostate, Breast, Lung, CRC), End User (Hospital, IRC) - Global Forecasts to 2030 - Product Image

Radiotherapy Market by Technology (EBRT:MR LINAC, Stereotactic, Particle; IBRT/Brachytherapy, Cobalt-60 Teletherapy), Procedure (IGRT, IMRT, 3D-CRT, HDR, LDR, PDR), Cancer (Prostate, Breast, Lung, CRC), End User (Hospital, IRC) - Global Forecasts to 2030

  • Report
  • 313 Pages
  • Global
From

About the Brachytherapy Market

Brachytherapy is a form of radiation therapy used in Nuclear Medicine and Radiopharmacology. It involves the placement of radioactive sources directly into or near a tumor, allowing for a higher dose of radiation to be delivered to the tumor while minimizing the dose to surrounding healthy tissue. Brachytherapy is used to treat a variety of cancers, including prostate, breast, and gynecological cancers. It is also used to treat benign conditions such as uterine fibroids. Brachytherapy is typically performed in an outpatient setting, and can be used as a primary treatment or in combination with other treatments such as surgery or external beam radiation therapy. The procedure is minimally invasive and can be completed in a single session. Some companies in the brachytherapy market include Elekta, Varian Medical Systems, C. R. Bard, and Nordion. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.